Covid-19: As lab execs sell shares worth millions, questions arise3 min read . Updated: 16 Nov 2020, 08:08 PM IST
- Several Moderna officials have sold shares worth more than $100 million in recent months
- Executives at Pfizer and Moderna were operating under a rule put in place by the SEC in 2000 to allow company employees to sell shares without facing insider-trading charges
Pfizer, Moderna, Novavax: executives at several American laboratories developing Covid-19 vaccines have recently pocketed millions of dollars by selling shares in their companies -- raising questions about the propriety of such a move in the midst of a national health crisis.
Select your Category